Healthcare Business - Page 2

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

A blockbuster drug is about to get a chance to have even higher sales. The U.S. Food and Drug Administration (FDA) has expanded its approval of Imbruvica for the treatment ...
Read Full Story »

Clementia Pharma Enters the Market With a Bang

Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) entered the market with a bang. The stock originally priced at $15 per share, which was at the high end of its expected price range. ...
Read Full Story »

Why Pfizer Earnings Aren’t Exciting Investors

Pfizer Inc. (NYSE: PFE) reported second-quarter 2017 results before markets opened Tuesday. The pharmaceuticals giant reported adjusted diluted earnings per share (EPS) of $0.67 and revenues of $12.9 billion. In ...
Read Full Story »

AbbVie Slips Despite Q2 Earnings Beat

AbbVie Inc. (NYSE: ABBV) reported its second-quarter financial results before the markets opened on Friday. The biotech giant posted $1.42 in earnings per share (EPS) and $6.94 billion in revenue, ...
Read Full Story »

Tetraphase Pharma Decides to Reap Profits With Secondary Offering

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) saw its shares pull back on Friday after the company announced that it has priced a secondary offering. Keep in mind that even though shares ...
Read Full Story »

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. While nowhere near the ...
Read Full Story »

Short Sellers Run for Cover From Major Biotech Stocks

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Pharma Short Interest Takes a Big Step Back

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Clementia Pharmaceuticals Announces Potential Pricing for IPO

Clementia Pharmaceuticals has filed an amended F-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price its 7.15 million ...
Read Full Story »

Reata Pharma Greenlights Phase 3 in Chronic Kidney Disease Trial

Reata Pharmaceuticals Inc. (NASDAQ: RETA) saw its shares kick off the week with an incredible gain after the company reported initial data from its mid-stage trial evaluating bardoxolone methyl (bardoxolone) ...
Read Full Story »

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) a close ...
Read Full Story »

Vertex Wins Big in Mid-Stage Cystic Fibrosis Trial

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) saw its shares make an incredible gain on Wednesday after the company announced results from its early and mid-stage trials in cystic fibrosis (CF). The ...
Read Full Story »

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Healthcare, which struggled mightily during the brutal election season last year and even back into 2015, has had a nice first half of 2017. Given the current nosebleed levels of ...
Read Full Story »

Gilead Secures FDA Approval For Chronic Hepatitis C Re-Treatment

Gilead Sciences, Inc. (NASDAQ: GILD) shares remained unchanged after the firm announced an approval from the U.S. Food and Drug Administration (FDA). Essentially, the FDA approved Vosevi (sofosbuvir 400 mg/velpatasvir ...
Read Full Story »

Puma Biotech Wins Big on FDA Approval of Breast Cancer Treatment

 Shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) touched a multiyear high Tuesday after the company reported a key approval by the U.S. Food and Drug Administration (FDA). Specifically, the agency ...
Read Full Story »